Strategic Shape Diagnostic
Enabling Technology
Value accrues by improving someone else’s product. In biopharma, this means delivery and formulation platforms. In devices, it means components and subsystems. In diagnostics, it means sample prep, chemistry, and licensed platforms. The ET shape is fundamentally different from drug development companies because the path to value does not require the ET company to own a clinical program — it requires them to make someone else’s program better.
Deal Structures
How this shape transacts
Licensing the platform to pharma or device companies for integration into their products
Tool-for-equity partnerships where technology access is exchanged for equity stakes in the partner’s programs
Acqui-hire transactions when the technology team is more valuable than the standalone business
Platform access agreements with recurring revenue from multiple licensees
Contradictions
Common contradictions for ET companies
Contradiction 01
Trying to become a drug company instead of monetizing the platform — ET companies that pivot into drug development often destroy shareholder value by competing with their own customers
Contradiction 02
Conflating platform improvement value with standalone product value — the technology is valuable because it improves other products, not because it is a product itself
Contradiction 03
Raising drug-development capital for an enabling technology business model
Counterparty View
What counterparties expect
Technology validation matters more than clinical data. Counterparties evaluating ET companies want to see evidence that the technology works in the context of existing products, not standalone clinical results. They look for validated integrations, existing partnerships or pilots, and a clear technical differentiation that justifies switching costs. The acquirer set for ET companies is distinct from drug development companies.
Find out if this is your shape.
The Shape Diagnostic classifies your company into one of seven archetypes in seven minutes.
Free classification · $49 full report